Nixon Gwilt Law

APRIL 22, 2024

That said, the flurry of regulatory policymaking and legislation, congressional hearings and inquiries, and industry stakeholder organization around the development and deployment of healthcare AI portends major developments in the coming years. HIPAA is the pantheon of healthcare data privacy regulation in the U.S. HIPAA What is it?

Healthcare 52

Healthcare Healthcare Training Food and Drug Administration 52

European Pharmaceutical Review

MARCH 12, 2024

Life science companies are increasingly using advanced technologies like artificial intelligence (AI), machine learning (ML) and blockchain to improve data quality and integrity by detecting anomalies in data and establishing tamper-proof audit trails for all data-related activities Data governance. How can this be mitigated?

Government 90

Government Pharma Ethics Training 90

PM360

JUNE 26, 2023

As shareholders and consumers demand greater transparency, accountability, and ethical behavior from corporations, pharmaceutical companies are expected to play a role in addressing these issues. These partnerships can be with local governments, healthcare providers, local startups, and non-governmental organizations.

Medicine 98

Medicine Marketing Pharma Manufacturing 98

European Pharmaceutical Review

OCTOBER 1, 2022

Sharing data across borders ensures access to safe tissues and cells for human application is ethical and supply quality is adequate, said the Council in a statement. Improving communication between public health authorities was also a key aim.

Ethics 92

Ethics Distribution Government Safety 92

Pharma Marketing Network

JULY 26, 2023

As new healthcare challenges arise and the pharmaceutical landscape evolves, the FDA may be allocating its resources to focus on other pressing issues, such as drug approvals, monitoring emerging health threats, and enhancing drug safety. The post Why Is FDA Issuing Fewer Marketing Violation Letters?

Marketing 97

Marketing FDA Food and Drug Administration Pharmaceutical 97

Clarivate

MARCH 17, 2022

How feasible is it to establish a drug’s safety for use in a population that may be unwilling or unable to participate in clinical trials? Margolis Center for Health Policy to convene a February 2021 public meeting about scientific and ethical issues associated with enrolling pregnant individuals in clinical trials for drug development.

Food and Drug Administration 10

Food and Drug Administration Safety FDA Ethics 10

PM360

JUNE 11, 2022

Only 5% of patients ranked pharma companies as the most trusted player in the healthcare space, according to a 2021 survey of 500 patients from Accenture. Be clear in your governance documents and training to level set expectations. For example, everyone must be steeped in both FDA and FTC guidelines. Rishi Kadiwar.

Patients 59

Patients Pharma Education Media 59